TCG Crossover portfolio
27 tracked investments, 9 on the map, $4.1B raised across the mapped portfolio.
- Ocular TherapeutixPost-IPO Equity
- Compass Pathways
- Mineralys TherapeuticsPost-IPO Equity
- Avalo Therapeutics
- CG OncologySeries F
- Mirador Therapeutics
- M3 BiotechnologyPost-IPO Equity
- CORXEL PharmaceuticalsSeries D
- AllakosPost-IPO Equity
Also in the portfolio
- Abivax
- Affinia Therapeutics
- Synthekine
- Carmot Therapeutics
- InflaRx
- Alkeus Pharmaceuticals
- Cidara Therapeutics
- Altimmune
- Pheon Therapeutics
- Savara Pharmaceuticals
- VistaGen
- Alpine Immune Sciences
- Magenta Therapeutics